ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Digital Automation Engineer —DeltaV Central Solutions and Transformation at Eli Lilly and Company - ApplyBlast

Digital Automation Engineer —DeltaV Central Solutions and Transformation

Eli Lilly and Company

5 months ago

4.0 on Glassdoor

Remote

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Digital Automation Engineer at Lilly develops and supports DeltaV transformation tools and associated AI applications to streamline drug substance manufacturing processes.

Responsibilities

Become a subject matter expert on DeltaV CLASS module library and support updates
Support and lead the development of a Digital strategy for DeltaV transformation tools
Develop and manage use cases for streamlining DeltaV delivery and CSV
Support DeltaV architecture design using reference standards and best practices
Interface with cross-functional teams to align project deliverables with business requirements

Skills

Qualifications

Bachelor's degree in engineering or related science5+ years of Process Automation experience with Emerson DeltaV Platform5+ years of API/Drug Substance manufacturing experienceExperience translating process and operational needs into digital requirementsPrevious experience with DeltaV Batch DCS

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.